搜索
市场行情
自选
新闻
分析
交易工具
选股器
扫码下载
一键诊股 让投资更聪明
English
繁体中文
ไทย
Tiếng việt
简体中文
Español
Português
Deutsch
한국어
日本語
登录
免费注册
搜索
免费注册
市场行情
/
股票
/
医药与医学研究
/
生物技术与医疗研究
/
cnsp
/
财务摘要
CNS Pharmaceuticals Inc
CNSP
添加自选
5.110
USD
-0.010
-0.20%
收盘 09-18 16:00(美东)
7.47M
总市值
亏损
市盈率 TTM
CNS Pharmaceuticals Inc
5.110
-0.010
-0.20%
概览
新闻分析
财务
股票评分
技术分析
预测
持股情况
股息
公司资料
财务摘要
利润表
资产负债表
现金流量表
财报
公司估值
风险评估
概览
新闻分析
财务
股票评分
技术分析
预测
持股情况
股息
公司资料
财务摘要
利润表
资产负债表
现金流量表
财报
公司估值
风险评估
CNSP 财务数据
通过专为投资者打造的一站式数据看板,全面查看 CNS Pharmaceuticals Inc 的财务状况。平台将复杂的财务报表整理为可自定义的视图,助您更轻松地进行财务分析。您可以查看最新年度财务报告,也可以通过利润表、资产负债表和现金流量表,按季度分析公司表现。借助实时财务指标,持续追踪公司的经营状况和市场表现更加便捷。
关键财务比率
总市值
7.47M
股息TTM
0.00
市盈率 TTM
-0.21
每股收益TTM
-24.12
营业收入
--
净利润
-14.86M
净资产收益率
-298.64%
总资产收益率
-179.17%
CNS Pharmaceuticals Inc 财报日历
最新发布
8月 12, 2026
每股收益 / 预测值
-0.38
/-0.24
营业收入 / 预测值
--
/0.00
财务报表摘要
单季报
单季报+年报
单季报
年报
YOY
隐藏空白行
FY2026Q2
FY2026Q1
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021Q4
FY2021Q3
财务指标
每股收益
94.10%
-0.38
61.43%
-7.30
90.27%
-9.70
96.20%
-5.76
99.84%
-6.42
99.84%
-18.93
99.69%
-99.72
99.53%
-151.64
87.04%
-4.03K
84.27%
-12.21K
71.51%
-31.70K
--
-32.48K
--
-31.11K
--
-77.61K
--
-111.29K
--
--
--
--
--
--
--
--
--
--
净利润
-8.97%
-2.59M
-14.78%
-4.94M
-87.50%
-5.96M
42.59%
-3.22M
6.16%
-2.37M
-21.34%
-4.30M
40.91%
-3.18M
-23.95%
-5.61M
37.07%
-2.53M
28.13%
-3.54M
2.34%
-5.38M
-32.26%
-4.52M
-12.77%
-4.02M
-56.48%
-4.93M
-69.17%
-5.50M
10.35%
-3.42M
6.50%
-3.57M
12.78%
-3.15M
-8.28%
-3.25M
-89.67%
-3.81M
资产负债率
-100.00%
0.00%
225.89%
4.99%
1.67%
3.81%
-38.37%
0.26%
-83.18%
0.84%
-88.06%
1.53%
-78.81%
3.75%
-76.62%
0.42%
93.52%
4.99%
229.11%
12.83%
463.10%
17.69%
--
1.80%
--
2.58%
--
3.90%
--
3.14%
--
--
--
--
--
--
--
--
--
--
利润表
营业利润
-12.06%
-2.70M
-14.70%
-4.98M
-87.06%
-5.99M
42.20%
-3.25M
4.70%
-2.41M
-22.36%
-4.34M
40.51%
-3.20M
-24.15%
-5.63M
37.20%
-2.53M
28.05%
-3.54M
2.23%
-5.38M
-32.61%
-4.53M
-12.93%
-4.03M
-56.44%
-4.93M
-69.21%
-5.50M
10.34%
-3.42M
6.48%
-3.56M
12.76%
-3.15M
-8.33%
-3.25M
-89.62%
-3.81M
净利润
-8.97%
-2.59M
-14.78%
-4.94M
-87.50%
-5.96M
42.59%
-3.22M
6.16%
-2.37M
-21.34%
-4.30M
40.91%
-3.18M
-23.95%
-5.61M
37.07%
-2.53M
28.13%
-3.54M
2.34%
-5.38M
-32.26%
-4.52M
-12.77%
-4.02M
-56.48%
-4.93M
-69.17%
-5.50M
10.35%
-3.42M
6.50%
-3.57M
12.78%
-3.15M
-8.28%
-3.25M
-89.67%
-3.81M
资产负债表
流动资产
55.07%
21.92M
-70.28%
4.08M
-6.42%
8.10M
54.19%
11.39M
558.98%
14.14M
756.94%
13.72M
444.16%
8.66M
258.32%
7.39M
-64.66%
2.15M
-77.03%
1.60M
-87.34%
1.59M
-76.30%
2.06M
-46.73%
6.07M
-52.68%
6.97M
68.03%
12.56M
-22.01%
8.70M
-17.91%
11.40M
15.23%
14.73M
-51.75%
7.48M
343.36%
11.16M
流动负债总额
170.30%
3.74M
64.89%
4.58M
62.46%
4.10M
-51.71%
1.96M
-79.55%
1.38M
-54.38%
2.78M
-58.84%
2.52M
-0.29%
4.06M
69.19%
6.76M
55.28%
6.09M
24.65%
6.13M
226.99%
4.07M
332.66%
4.00M
266.87%
3.92M
89.66%
4.92M
-48.31%
1.24M
-49.54%
923.86K
-43.77%
1.07M
36.15%
2.59M
371.32%
2.41M
总资产
51.21%
21.94M
-66.16%
4.65M
-0.89%
8.62M
60.19%
11.87M
487.54%
14.51M
727.83%
13.75M
411.56%
8.70M
218.26%
7.41M
-61.73%
2.47M
-77.60%
1.66M
-86.97%
1.70M
-75.84%
2.33M
-48.17%
6.45M
-53.28%
7.41M
49.05%
13.05M
-16.25%
9.64M
-12.58%
12.45M
20.75%
15.87M
-44.76%
8.76M
285.48%
11.51M
总负债
170.30%
3.74M
64.89%
4.58M
62.46%
4.10M
-51.71%
1.96M
-79.55%
1.38M
-54.38%
2.78M
-58.84%
2.52M
-0.29%
4.06M
69.19%
6.76M
55.28%
6.09M
24.65%
6.13M
226.99%
4.07M
332.66%
4.00M
266.87%
3.92M
89.66%
4.92M
-48.31%
1.24M
-49.54%
923.86K
-43.77%
1.07M
36.15%
2.59M
371.32%
2.41M
总权益
38.67%
18.20M
-99.36%
70.70K
-26.78%
4.52M
195.62%
9.91M
405.69%
13.12M
347.60%
10.97M
239.36%
6.18M
292.58%
3.35M
-274.93%
-4.29M
-226.88%
-4.43M
-154.50%
-4.43M
-120.74%
-1.74M
-78.70%
2.45M
-76.41%
3.49M
31.96%
8.13M
-7.76%
8.39M
-7.13%
11.52M
31.66%
14.80M
-55.81%
6.16M
267.76%
9.10M
现金流量表
经营净额
33.76%
-3.54M
-43.39%
-4.65M
44.22%
-3.05M
68.03%
-2.17M
-223.76%
-5.34M
-1.56%
-3.24M
-115.70%
-5.47M
-101.40%
-6.80M
51.50%
-1.65M
33.84%
-3.19M
-10.02%
-2.54M
-86.25%
-3.38M
-1.20%
-3.40M
-56.79%
-4.82M
28.78%
-2.31M
9.16%
-1.81M
32.72%
-3.36M
6.98%
-3.08M
-123.73%
-3.24M
-56.67%
-2.00M
投资净额
--
-3.82K
--
-6.18K
-333.98%
-18.18K
--
--
--
--
--
--
-94.16%
-4.19K
--
--
--
--
--
--
-215800.00%
-2.16K
-15.19%
-1.74K
--
--
--
--
100.05%
1.00
--
-1.51K
--
-2.91K
100.00%
0.00
--
-2.08K
--
0.00
融资净额
364.97%
20.58M
-95.88%
404.66K
-91.80%
406.87K
-100.75%
-91.62K
90.20%
4.43M
184.17%
9.83M
127.92%
4.96M
146826.13%
12.28M
-9.52%
2.33M
2975.33%
3.46M
-59.17%
2.18M
107.14%
8.36K
2313.46%
2.57M
-101.14%
-120.28K
6538.96%
5.33M
-103.41%
-117.14K
-114.37%
-116.17K
2925.97%
10.51M
-100.58%
-82.83K
7735.92%
3.44M
常见问题
CNS Pharmaceuticals Inc的流动资产是多少?
根据CNS Pharmaceuticals Inc的FY2025财报,流动资产为8.10M(同比变化-6.42)。
CNS Pharmaceuticals Inc的总资产是多少?
根据CNS Pharmaceuticals Inc的FY2025财报,CNS Pharmaceuticals Inc的总资产为8.62M(同比变化-0.89)。
CNS Pharmaceuticals Inc的总负债是多少?
根据CNS Pharmaceuticals Inc的FY2025财报,CNS Pharmaceuticals Inc的总负债为4.10M(同比变化62.46)。
CNS Pharmaceuticals Inc的总权益是多少?
根据CNS Pharmaceuticals Inc的FY2025财报,CNS Pharmaceuticals Inc的总权益为4.52M(同比变化-26.78)。
CNS Pharmaceuticals Inc的净营业收入是多少?
根据CNS Pharmaceuticals Inc的FY2025财报,CNS Pharmaceuticals Inc的净营业收入为-15.99M(同比变化-7.28)。
CNS Pharmaceuticals Inc的净投资是多少?
根据CNS Pharmaceuticals Inc的FY2025财报,CNS Pharmaceuticals Inc的净投资为-18.18K(同比变化-333.98)。
CNS Pharmaceuticals Inc的净融资是多少?
根据CNS Pharmaceuticals Inc的FY2025财报,CNS Pharmaceuticals Inc的净融资为14.57M(同比变化-36.74)。
CNS Pharmaceuticals Inc的每股收益(EPS)是多少?
根据CNS Pharmaceuticals Inc的FY2025财报,每股收益(EPS)为-35.75(同比变化92.34)。
CNS Pharmaceuticals Inc的净利润是多少?
根据CNS Pharmaceuticals Inc的FY2025财报,净利润为-15.85M(同比变化-6.68)。
CNS Pharmaceuticals Inc的债务与资产比率是多少?
根据CNS Pharmaceuticals Inc的FY2025财报,债务与资产比率为3.81(同比变化1.67)。
CNS Pharmaceuticals Inc的股东权益回报率(ROE)是多少?
根据CNS Pharmaceuticals Inc的FY2025财报,股东权益回报率(ROE)为-296.30(同比变化82.61)。
CNS Pharmaceuticals Inc的资产回报率(ROA)是多少?
根据CNS Pharmaceuticals Inc的FY2025财报,资产回报率(ROA)为-182.99(同比变化35.95)。
CNS Pharmaceuticals Inc的营业利润是多少?
根据CNS Pharmaceuticals Inc的FY2025财报,营业利润为-15.99M(同比变化-7.28)。